Empowered Funds’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $930K | Sell |
2,853
-3,048
| -52% | -$994K | 0.01% | 1100 |
|
|
2025
Q1 | $1.59M | Sell |
5,901
-1,729
| -23% | -$467K | 0.02% | 839 |
|
|
2024
Q4 | $1.8M | Buy |
7,630
+566
| +8% | +$133K | 0.03% | 779 |
|
|
2024
Q3 | $1.94M | Buy |
7,064
+5,362
| +315% | +$1.47M | 0.03% | 686 |
|
|
2024
Q2 | $414K | Sell |
1,702
-12,147
| -88% | -$2.95M | 0.01% | 1106 |
|
|
2024
Q1 | $2.07M | Buy |
13,849
+524
| +4% | +$78.3K | 0.04% | 603 |
|
|
2023
Q4 | $2.55M | Buy |
13,325
+11,873
| +818% | +$2.27M | 0.06% | 430 |
|
|
2023
Q3 | $257K | Buy |
1,452
+134
| +10% | +$23.7K | 0.01% | 1092 |
|
|
2023
Q2 | $250K | Sell |
1,318
-17
| -1% | -$3.23K | 0.01% | 1014 |
|
|
2023
Q1 | $267K | Buy |
+1,335
| New | +$267K | 0.02% | 467 |
|
|
2022
Q4 | – | Sell |
-1,031
| Closed | -$206K | – | 237 |
|
|
2022
Q3 | $206K | Buy |
+1,031
| New | +$206K | 0.02% | 308 |
|